Open original FDA record ↗Recall record
- FDA identifier
- Z-3113-2011
- Company in FDA record
- Express Diagnostics Int'l., Inc.
- FDA classification date
- Aug 31, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Express Diagnostics Int'l, Inc (EDI), is recalling DrugCheck Drug Screen Cups containing buprenorphine (BUP) and propoxyphene (PPX) because they must be labeled as "forensic use only", meaning they cannot be distributed or used for treatment or diagnostic purposed in the United States.
Source facts
- Action
- The firm, Express Diagnostics Int'l, Inc., sent a "RECALL NOTICE" letter dated October 4, 2010 to its customers. The letter described the product, problem and actions to be taken. The customers were instructed to notify their customers of the labeling change, and complete and return the DISTRIBUTOR/CUSTOMER CONFIRMATION FORM via fax to Express Diagnostics Int'l, Inc., at 1-507-526-2252. The letter also noted that "Further shipment of product containing BUP and/or PPX cannot continue until Express Diagnostics Int'l, Inc. receives the signed form." If you have any questions, call 507-526-3951.
- Initiated
- 2010-10-04
- Root cause
- Labeling False and Misleading
- Terminated
- 2012-07-06
- Distribution
- Nationwide distribution:AZ, CA, CT, GA, MD, MA, MN, MO, NH, NJ, OR, SC, and WA.
- Recall number
- Z-3113-2011
- Recall status
- Terminated
- CDRH record ID
- 103203
- FDA classified
- 2011-08-31
- Recall event number
- 59632